Fhabián S Carrión-Nessi, Luis C Ascanio, Andreína G Pineda-Arapé, Óscar D Omaña-Ávila, Daniela L Mendoza-Millán, Sinibaldo R Romero, Abranny B Almao-Rivero, Natasha A Camejo-Ávila, Karim J Gebran-Chedid, Carlis M Rodriguez-Saavedra, Diana C Freitas-De Nobrega, Sergio A Castañeda, José L Forero-Peña, Lourdes A Delgado-Noguera, Lucianny K Meneses-Ramírez, Juan C Cotuá, Alfonso J Rodriguez-Morales, David A Forero-Peña, Alberto E Paniz-Mondolfi
BACKGROUND: Persistent headache is a frequent symptom after coronavirus disease 2019 (COVID-19) and there is currently limited knowledge about its clinical spectrum and predisposing factors. A subset of patients may be experiencing new daily persistent headache (NDPH) after COVID-19, which is among the most treatment-refractory primary headache syndromes. METHODS: We conducted a cross-sectional study in Latin America to characterize individuals with persistent headache after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to identify factors associated with NDPH...
December 14, 2023: BMC Infectious Diseases